Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.
South Asian J Cancer
; 10(4): 213-219, 2021 Dec.
Article
de En
| MEDLINE
| ID: mdl-34984198
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Etiology_studies
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Langue:
En
Journal:
South Asian J Cancer
Année:
2021
Type de document:
Article
Pays d'affiliation:
Inde
Pays de publication:
Inde